To investigate the role of JAM-C during e-EPC recruitment to sites of tumor angiogenesis in vivo, we used the syngeneic Lewis-Lung-Carcinoma (LLC) tumor model in the dorsal skin-fold chamber. This evidence concerns the gene JAM3 and lung carcinoma.